Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
about
Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic reviewPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisEvaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort StudyHPV vaccination in women aged 27 to 45 years: what do general practitioners think?Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter.Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study.Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in NorwayThe Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort StudyDeterminants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.Sexually transmitted infections after bereavement - a population-based cohort studySchool-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study.Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based studyEfficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs.To Consent or Decline HPV Vaccination: A Pilot Study at the Start of the National School-Based Vaccination Program in SwedenThe facial affective scale as a predictor for pain unpleasantness when children undergo immunizations.Clinical trials of human papillomavirus vaccines and beyond.Factors impacting HPV vaccination: lessons for health care professionals.Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer.Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs.The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.Cervical neoplasia in systemic lupus erythematosus: a nationwide study.Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.Expectation prior to human papilloma virus vaccination: 11 to 12-Year-old girls' written narratives.Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program.Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women.Reply to Ryser et al.Universal proposal strategies of anti-HPV vaccination for adolescents: comparative analysis between school-based and clinic immunization programs.Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy.Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis.
P2860
Q28081927-2973AB00-5755-4160-9014-3D34C10B0484Q28084924-7231182A-A7F3-401F-87E3-F10C472F6341Q28647510-DBE3EFA5-96B5-4446-BBF7-F33C0EDA3EFFQ34108157-9F6E695E-AB29-42B8-A13A-83A03D980A71Q34311160-67031899-636A-4DAD-90FA-C6B8226800D5Q35032459-2F41BD64-F424-44AC-AE3A-A9F28DF8336EQ35088687-49306A2F-0CFD-401C-97DA-A23634E066D8Q35126586-B96E55CB-8429-4378-A3E4-8193EF32FDA6Q35127307-8E734323-7FB6-45F9-9B6E-B337579C130EQ35640169-FE74E982-DF4E-4763-8315-F160B93B68ADQ35719771-5F6B871F-A0FF-48D9-B87D-77E3C3B75E73Q35774921-61080F4C-5D13-4222-8DE5-25964DB60EFDQ36104638-071329AA-7751-4EDF-A12E-FBB2C94148E4Q36526842-6B6E4EFB-536A-4682-8B4F-46BA98816001Q36679762-CC4A683F-B5F5-4416-8B49-E0DF596B5EADQ37130168-C1B69179-0BF7-4F13-966B-F0F5222BBF4EQ37135485-9F702DE8-588F-4DDC-B7C9-2DF0B6930034Q37349077-3C760F1D-B5DE-4858-9E69-61662CEF6DCAQ37467138-3C4C2C67-987E-4B01-894A-F669B2269B69Q37505526-A0C869DB-7A69-4AD7-8D41-2F13DCCB7008Q37661631-6A1FEBCD-AB87-4471-918F-C3DF2F8CA398Q38111962-063789B5-7131-4554-B93B-6569C4003DDEQ38223242-045818E3-A2ED-4119-8E19-C235D6457BE3Q38229304-44F9A007-1BB3-46EC-ABC3-B969F1C13390Q38733067-0D0741CE-A367-4778-A330-D5C86A181EE4Q38986304-E5462DCE-8C5C-4AC5-B81B-5A1994A1F129Q39278938-AC56979B-F391-46B7-A442-4A654159F6C0Q40080797-F0FDBD52-1DDC-4BBF-BF38-F03117385CAFQ40168801-92932619-1F2C-4DEA-A3EC-76184A5D122AQ40401221-8E298DAE-721E-44D2-B2BE-59BADA73B621Q40593455-7C4706B1-42AB-4073-9F6E-B4E591926812Q40603338-F9201B01-FC2D-4980-9F0F-BC6E9E5805B0Q42220415-04097447-89A1-439A-9DCC-D4C937FD16DAQ42236236-3FB54041-1D4C-4BB7-99F1-7F33645084D5Q44701708-E0808C91-ABA1-4612-ABE0-72E6CF81D4F2Q44732567-1D4D7845-4AE7-4C2B-B892-C9BCD3D126FDQ47232925-6001B2C6-DD8C-413A-83A3-7AC70F8867B3Q48168601-A05941B8-EE6B-4900-8AA9-F84DD37D7E05Q54245844-64369019-0C44-421A-840D-EAE019BD18C3Q54266157-22A68026-9780-46F8-AB06-9C1EF1DB76D5
P2860
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@ast
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@en
type
label
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@ast
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@en
prefLabel
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@ast
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
@en
P2093
P2860
P356
P1476
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study
@en
P2093
Cecilia Young
Eva Herweijer
Eva Netterlid
Joakim Dillner
Julia Fridman Simard
Pär Sparén
Sandra Eloranta
P2860
P304
P356
10.1093/JNCI/DJT032
P407
P577
2013-03-13T00:00:00Z